Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

On Tuesday, 20 May 2025, Regeneron Pharmaceuticals (NASDAQ:REGN) presented at the RBC Capital Markets Global Healthcare Conference ... Factor XI Program: This initiative aims to develop a safer ...

Here’s a look at their latest initiatives: Apple is preparing to launch an AI-powered health service as part of an initiative called “Project Mulberry.” The service features an AI-driven ...

DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company ... The new Truveta Genome Project initiative aims to generate genetic data on tens ...

Illumina and Regeneron ... improving the health of our families and communities, and lowering the cost of care.” “Discoveries from smaller datasets before today’s AI have led to important ...

Drugmakers, including Regeneron, have committed to additional investments to boost production in the U.S. amid concerns about healthcare funding cuts and mass layoffs at the FDA. "Obviously ...

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands ...